Cantor Fitzgerald reiterates Overweight rating on Taysha Gene Therapies stock By Investing - Stock Watch Index

Cantor Fitzgerald reiterates Overweight rating on Taysha Gene Therapies stock By Investing

September 22, 2025

Cantor Fitzgerald reiterates Overweight rating on Taysha Gene Therapies stock

Search

RECENT PRESS RELEASES

Wheels Up investors extend share lock-up period by eight months By Investing.com

SWI Editorial Staff2025-09-22T07:22:00-07:00September 22, 2025|

Oracle names Magouyrk and Sicilia as new co-CEOs By Investing.com

SWI Editorial Staff2025-09-22T07:21:35-07:00September 22, 2025|

Fox, Snap and ASML rise premarket; Kenvue and Coinbase fall By Investing.com

SWI Editorial Staff2025-09-22T07:21:08-07:00September 22, 2025|

Cantor Fitzgerald reiterates Overweight rating on Taysha Gene Therapies stock By Investing

SWI Editorial Staff2025-09-22T07:20:36-07:00September 22, 2025|

Tesla stock target lifted at Piper Sandler after China trip By Investing.com

SWI Editorial Staff2025-09-22T07:19:57-07:00September 22, 2025|

Caesars Entertainment stock rating reiterated at Overweight by JPMorgan By Investing.com

SWI Editorial Staff2025-09-22T07:19:24-07:00September 22, 2025|

Related Post